>>>Apple + Samsung = 106% of handset operating profits in Q1

Apple + Samsung = 106% of handset operating profits in Q1

Canccord Genuity's U.S. surveys indicated the Galaxy S5 was the #1 selling smartphone at all four tier-1 U.S. carriers in April (iPhone 5S was #2). They believe Apple and Samsung (SSNLF) once again dominated handset industry operating profits and combined to capture a remarkable 106% of Q1/14 handset industry profits as other leading OEMs such as BlackBerry, Nokia (MSFT), and HTC posted operating losses or near breakeven results. Thet believe their RFIC coverage cos AVGO, SWKS, RFMD, and TQNT and baseband supplier QCOM are well positioned to benefit from the China TD-LTE smartphone ramp for the remainder of 2014. They anticipate re-accelerating smartphone-derived royalties for ARMH in H2/14.

>>> (Makor) MRPT - Top Trading Ideas - LONG ENI / SHORT TOTAL, IXC


Trade action flash – Long ENI / Short Total, ishares global energy (IXC)

May 08, 2014

MRPT© mean reverting pair trading strategies      TOP TRADING IDEAS

ENI IM: Eur 18.88; FP FP: Eur 52.05; IXC US: US$ 47.12

We recommend going long ENI while shorting Total and the iSHARES global energy ETF (IXC US).  The stock has been underperforming the sector since early 2013 and has become as a result one of the most attractive global oil companies from a relative value basis.  ENI is particularly mean reverting with Total and the iSHARES global energy ETF.  We could target easily a 5-10% relative performance come-back for ENI.  The trade is added to our Top Trading Ideas portfolio.

Full report attached

 

Makor Capital

11 Menachem Begin St., 26th FL

Ramat Gan 52681

Israel

 

Tel          +972 3 5453 768

Fax         +972 3 7162 680

 

Research Disclaimer

This publication has been prepared by Makor Capital Limited (“Makor Capital”) and is intended for professional or qualified investors only. Makor Securities LLP (“Makor Securities”)is distributing this material to its clients who are Eligible Counterparties or Professional Clients under FSA Rules. It may also be disseminated to persons who are Investment Professionals within the meaning of the Financial Services and Markets Act 2000 (Financial Promotion) order 2005.  In the United States Makor Capital only distributes this material to major US institutional investors (as that term is defined in Rule 15 a-6 of the Securities and Exchange Act of 1934) and to SEC registered broker-dealers or  banks acting in a broker –dealer capacity” If you do not fall into any of these categories you should disregard it.

 

This research material is a marketing communication.  It is not investment research and has not been prepared in accordance with legal requirements designed to promote the independence of investment research. It is not subject to any prohibition on dealing ahead of the dissemination of investment research.   It has not been produced by Makor Securities. 

 

This material does not take into account the particular investment objectives, financial situation or needs of individual clients or other recipients. Before acting on this material, clients and other recipients should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice.

This material should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action.

This material is produced by research providers which Makor Securities believes to be reliable, but Makor Securities does not warrant or represent (expressly or impliedly) that it is accurate, complete, not misleading or as to its fitness for the purpose intended and it should not be relied upon as such.

Opinions expressed will be the current opinions of those producing the research as of the date appearing on this material only. We expect those producing the material in  this report to update it on a timely basis but can give no undertaking that they will do so and regulatory compliance or other reasons may prevent  them from doing so (or us from disseminating updated material). 

 

Members and employees of Makor Securities LLP, employees of Makor Capital, Makor Capital Markets and any firm producing this material (including Alternative Investment Management Research SA (“AIM&R”),) may from time to time have long or short positions in securities, warrants, futures, options, derivatives or other financial instruments referred to in this material. For Makor Securities, this information is set out in our Conflicts of Interest Policy which is available on request.  Policies for the production of research from research providers (including AIM&R) are available on request.

Unless otherwise stated, share prices provided within this material are as at the close of business on the day prior to the date of the material.

Neither the whole nor any part of this material may be duplicated in any form or by any means. Neither should any of this material be redistributed or disclosed to anyone without prior consent. This material is issued for general information and discussion purposes only. None of  Makor Securities, Makor Capital, Makor Capital Markets nor AIM&R accepts  liability whatsoever for any direct, indirect or consequential loss or damage of any kind arising out of the use of all or any of this material.

 

The services, securities and investments discussed in this material may not be available to, nor are suitable for all investors. Investors should make their own investment decisions based upon their own financial objectives and financial resources and it should be noted that investment involves risk, including the risk of capital loss. Past performance is no guide to future performance. In relation to securities denominated in foreign currency, movements in exchange rates will have an effect on the value, either favourable or unfavourable.

 

Entities

 

Makor Securities LLP is authorised and regulated by the Financial Services Authority (FSA registration number 556034) of Dover House, 34 Dover Street, London W1S 4NG.

Makor Capital, company number 514456466, is incorporated in Israel and is a 100% held subsidiary of Makor Holdings Pte Ltd incorporated in Singapore.

Makor Capital Markets SA, company number CH-660.2.999.011-0 is incorporated in Switzerland and is also a 100% held subsidiary of Makor Holdings Pte Ltd.

AIM&R is incorporated in Switzerland; company number CH-660.1.533.997-8

 

 

>>> Fed's Tarullo (dovish, FOMC voter): Should replace risk-weighted capital with measures based on stress tests

Fed's Tarullo (dovish, FOMC voter): Should replace risk-weighted capital with measures based on stress tests; one size fits all approach to bank regulation has been abandoned - comments from Bank Regulation Conference in Chicago - Threshold for enhanced bank supervision could be raised to $100 billion from $50 billion. - Financial regulation needs to be broadened to cover non-bank financial firms. - Need to re-examine exclusion of small community banks from certain financial activities. - Need to establish minimum margin requirements for securities financing.

WSJ : Hedge Funds Extend Their Slide

Hedge Funds Extend Their Slide Hedge Funds Post Back-to-Back Monthly Declines

A bumpy trading environment is tripping up hedge funds.

Big stumbles by some star managers drove hedge funds to back-to-back monthly declines for the first time in two years, according to researcher HFR Inc.

The lackluster showing—the average hedge fund trailed benchmarks for both stocks and bonds in April—was a blow for an industry that charges more than other fund managers but pitches steady returns in both good times and bad.

Hedge funds on average dropped 0.17% in April, HFR said Wednesday, following a 0.33% decline in March. Funds hadn't turned in two consecutive losing months since April and May of 2012, HFR said.

That performance also trailed the broader stock market, where the S&P 500 rose 0.74% in April, including dividends. Many hedge funds, however, invest in markets other than stocks, and bet concurrently on some positions rising and others falling.

Brad Balter, a Boston-based adviser who helps wealthy investors choose hedge funds, said his clients increasingly are weighing whether they should continue pouring money into these highly paid managers.

"I'm not saying you should judge people in a single quarter, but there's less rope for poor performance," Mr. Balter said. He called the industry's showing in recent years for the most part "mediocre."

The latest industrywide figures come the same week a survey by the trade publication Institutional Investor's Alpha showed that the top 25 highest-earning hedge-fund managers collectively made $21 billion in 2013, an increase of more than 50% over 2012.

Most hedge funds charge some variation of the "2 and 20" model, in which the firm collects a 2% management fee and 20% of investment profits.

Some of the biggest losers among fund managers in April were those who tried to ride last year's big winners: tech stocks.

Coatue Management LLC, the $9 billion New York firm started by Philippe Laffont, a veteran of Julian Robertson's Tiger Management, slid about 4% for its second consecutive month of losses due mostly to tech-related stocks, according to people familiar with its results. Coatue is now down almost 11% for the year, and has given back more than half of its gains from 2013.

Hedge funds that bet on technology and health care as a group fell 3.7%, the steepest drop since 2008, according to HFR.

Jonathan Lennon, founder of hedge fund Pleasant Lake Partners, said it was challenging to navigate an environment in which many technology, media and telecommunications stocks are trading at "nosebleed valuations." He has maintained bets against technology and consumer stocks, which has helped $100 million Pleasant Lake gain about 12% this year.

The pain wasn't limited to tech stocks.

Paul Tudor Jones, a billionaire veteran of the industry and founder of Tudor Investment Corp., this week called the trading environment "as difficult as I've ever seen in my career." Mr. Jones' main fund is down about 4% this year, according to investor documents.

Sloane Robinson LLP, one of London's oldest hedge-fund firms, did even worse, recording a 20% yearly loss in its International fund. The fund has been hurt in part by bets against the Japanese yen, an investor said, a favorite hedge-fund trade from the past year that has hurt managers in 2014. Co-founder Hugh Sloan didn't respond to a request for comment.

But several boldfaced names in the industry shined.

William Ackman's Pershing Square L.P. hedge fund rose 7.3% last month, according to an investor update, helped by the activist's deal to back Valeant Pharmaceuticals International Inc.'s takeover attempt of wrinkle-treatment maker Allergan Inc.

Pershing Square L.P. is up 18.7% for the year through the end of April, according to the document viewed by The Wall Street Journal. The firm manages $13.7 billion overall.

Astenbeck Capital Management, the $3.4 billion commodities hedge-fund firm led by oil trader Andy Hall, gained 3.1% in April and is up more than 11% on the year, according to investor documents.

For some big firms, the problems arose when they switched gears at the wrong time. Quantitative Investment Management LLC, a $2.7 billion firm based in Charlottesville, Va., that frequently shifts its positions based on the firm's models, flipped to shorting U.S. equities early in the month, and began posting losses midmonth as stock indexes rallied, according to an investor communication.

Adding to the firm's pain: QIM had been betting for much of the month on further appreciation for U.S. Treasurys, a haven asset whose prices dropped as stocks rose. QIM's flagship fund ended the month down about 5%, and is now 6% in the red for 2014 overall.

For at least one big fund, staying the course turned out to be the right move.

Viking Global Investors LP, a $27 billion Greenwich, Conn. firm, was down almost 4% in the first two weeks of the month in its flagship fund, in part due to poor-performing bets on tech stocks, but told investors it intended to maintain its positions and ride out the turmoil.

After dropping 3.4% in the first two weeks of April, the Nasdaq-100 tech index roared back with a 4% return in the back half of the month. Viking ended up about 0.4% for April.

>>> US Gapping down

Gapping down

In reaction to disappointing earnings/guidance/SSS: POWR -35.5% ( downgraded to Hold from Buy at Craig Hallum), MM -32.7% (multiple downgrades), GPOR -15.1%, BODY -14.9%, MCP -11%, EGY -9.3% (light volume), NPSP -9%, LQDT -9%, ERII -8.9%, DF -7.8%, TSLA -6.4%, SCMP -6.2%, ANDE -4.7%, (light volume), NICE -4.3%, NLY -4.1%, REE -3.8% (light volume), CZR-3.7%, ICPT -3.7%, REGN -3.7%, NVAX -3.5%, (light volume), CLR -2.7%, PMT -2.5%, (light volume), GTAT -2.3%, ARP -2.1%, RNDY -1.7% (light volume), WIN -1.6%, LPSN -1.5% (light volume), LCI -1.5%, VNDA -1.3%, INSM -1.2%, SUNE -1.1%, EMKR -1.1%, (light volume), FANG -1%, TWO -0.9%, SN -0.8% (light volume).

Casino/gaming names lower following reports that Macau may be limiting illegal money transfers: LVS -6.1%, MPEL -5.7% (also reported earnings), WYNN -5.3%, MGM -4.6%

Other news: CIE -5.7% ( announces $1 bln offering of convertible senior notes due 2024), FDX -0.4% ( FedEx may charge by size of packages, according to reports; also downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $140 from $160) .

Analyst comments: QRE -3% (downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $19 from $20 on lack of immediate catalysts, preferring NSLP or Legacy Reserves), CLF -0.6% (downgraded to Underperform from Mkt Perform at Bernstein)

>>> US Gapping up

Gapping up

In reaction to strong earnings/guidance/SSS: PME +31.1%, SCTY +10.7%, SFM +6.8%, COUP +6.3%, MRIN +6.1% (light volume), WEN +5.6%, JASO +5.6%, CSLT +5.5%, GMCR +5.3%, HIMX +5.3%, GTXI +4.7%, DCTH +4.6%, (light volume), BRKR +4.4%, (light volume), AVG +3.9%, (light volume), Z +3.6%, RIG +3.6%, SD +3.3%, BT +3.2%, )li CTRP +3.1%, BRDR +2.9%, HK+2.6%, APA +2.6% (light volume), CAR +2.5%, FOXA +2.4%, RATE +2.2%, (announces acquisition of Caring for $54 mln in cash), AGO +2.2%, (light volume), JONE +2.2%, (light volume), AXAS +2%, PNNT +1.7%, (light volume), KIM +1.7%, (light volume), ATLS +1.5%, (light volume), STB +1.4%, EFC +1.1%, COST +1.1%, CTL +1%, MATR +1%, (light volume), PRU +0.6%, PUK+0.6%, POZN +0.9% (light volume), MCD +0.2%.

M&A news: AZN 2.1% (Pfizer may bid a higher amount for AZN, according tor reports ), CHTP halted (Lundbeck to Acquire Chelsea Therapeutics; total potential consideration of up to USD 7.94 per share).

A few financial related names showing strength: BCS +6% (provides strategy update; to cut 14,000 jobs by end of year), NBG +3.3%, DB +1.5%, SAN +1%.

Metals/mining stocks trading higher: MT +2.9%, HMY +2.3%, PAAS +0.8%, GDX +0.6%, GLD +0.3%, GOLD +0.2% (reports Q1 metrics) .

Select oil/gas related names showing strength: SDRL +3.8%, PBR +1.2%, TOT +1%, STO +0.4%, RDS.A +0.3%.

Other news: WBAI +4.9% (reiterates that it has obtained proper approvals to operate an online sports lottery service in China), ROIC +3.5% ( ROIC to replace ACO in the S&P SmallCap 600), GRPN +2.3% (still checking), TWTR +2.1% (following positive Barron's mention; upgraded to Equal-Weight from Underweight at Morgan Stanley), RDN +1.8% (prices 15.5 mln share offering of common stock at $14.50 per share; increases size and prices $300 mln offering of senior notes), CAJ +1.5% (confirmed plans to acquire its own shares -- up to 17 mln shares of common stock), F +1% (announces $1.8 bln stock repurchase program to offset share dilution; consistent with capital strategy), BMRN +0.9% (positive MadMoney mention), GILD +0.7% ( announce $5 bln share buyback program), SODA +0.7% (following GMCR results), CREE +0.6% (increases stock buyback to $300 mln), TFM +0.2% (following SFM results).

Analyst comments: GIMO +5.4% (upgraded to Outperform from Neutral at Credit Suisse ), YELP +3.3% (Yelp upgraded to Overweight from Equal Weight at Morgan Stanley), SJM +0.7% (upgraded to Neutral from Sell at Goldman), DGX +0.6% (upgraded to Neutral from Underperform at BofA/Merrill; tgt raised to $58 from $50)

>>> US Early premarket gappers

Early premarket gappers

Gapping up: PME +19.8%, SCTY +9.5%, SFM +6.8%, COUP +6.3%, MRIN +6.1%, BCS +6%, GMCR +5.3%, HK +4.9%, DCTH +4.6%, BRKR +4.4%, AVG +3.9%, SDRL +3.8%, Z +3.6%, RIG +3.6%, ROIC +3.5%, NBG +3.3%, CTRP +3.1%, BRDR +2.9%, YELP +2.8%, CAR +2.5%, SUNE +2.5%, FOXA +2.4%, HMY +2.3%, GRPN +2.3%, JASO +2.2%, RATE +2.2%, AGO +2.2%,JONE +2.2%, AZN +2.1%, TWTR +2.1%, SD +1.8%, PNNT +1.7%, DB +1.5%, ATLS +1.5%, PBR +1.2%, LPSN +1.2%, EFC +1.1%, F +1%, CTL +1%, MATR +1%, GILD +0.7%, SODA +0.7%

Gapping down: POWR -35.5%, MM -32.7%, GPOR -15.1%, BODY -14.9%, EGY -13.8%, MCP -11%, ERII -8.9%, TSLA -6.4%, SCMP -6.2%, CIE -5.7%, ANDE -4.7%, NLY -4.1%, REE -3.8%, CZR -3.7%, ICPT -3.7%, NVAX -3.5%, PMT -2.5%, ARP -2.1%, RNDY -1.7%, MGM -1.6%, LVS -1.6%, LCI -1.5%, WYNN -1.4%, EMKR -1.1%, FANG -1%, GTAT -1%, TWO -0.9%, SN -0.8%

>>> United Utilities subject of takeover talk; LongRiver Partners mentioned as possible bidder

United Utilities subject of takeover talk; LongRiver Partners mentioned as possible bidder United Utilities, a listed UK-based water utility, was the subject of takeover speculation yesterday, 7 May, the Financial Times reported. The newspaper’s market report section did not cite a source for the speculation, but noted that water utilities in general were boosted after the UK’s shadow energy secretary downplayed the prospect that of a freeze on water prices.

Traders cited by the report mentioned speculation that LongRiver Partners, a consortium led by Borealis, might be interested in United Utilities.

Better clarity with regards to political and regulatory issues has sparked renewed hopes of takeovers in the water sector from sovereign wealth funds and infrastructure funds, the item said.

United Utilities’ share price closed 12.5p up at 816.5p in London yesterday, giving the company a market capitalisation of GBP 5.56bn (EUR 6.77bn).

http://www.ft.com/cms/s/0/3e7291e0-d608-11e3-a017-00144feabdc0.html?siteedition=uk on 07.05.2014

Source Financial Times